Navigation Links
Denosumab Demonstrates Superiority Over Zometa(R) in Delay of Complications Due to Bone Metastases in Advanced Breast Cancer Patients
Date:9/22/2009

cent in breast and prostate cancer patients.

With bone metastases the growing cancer cells weaken and destroy the bone around the tumor. The damage the tumor has caused to the bone can result in a number of serious complications, collectively called SREs. These include fracture of a bone, the need for radiation to bone, the need for bone surgery, or spinal cord compression. All are serious complications for advanced cancer patients.

The economic burden of United States (U.S.) patients with bone metastases is significant and was estimated to be $12.6 billion last year.(4) Patients with bone metastases who experience an SRE incur significantly higher medical costs compared with those who do not experience an SRE.(5)

About Amgen

Amgen discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit www.amgen.com.

Forward-Looking Statements

This news release contains forward-looking statements that are based on management's current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions that could cause actual results to differ materially from those described. All statements, other than statements of historical fact, are statements that could be
'/>"/>

SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Amgen to Collaborate With GlaxoSmithKline to Commercialize Denosumab in Europe for Postmenopausal Osteoporosis (PMO)
2. FDA Accepts Amgens Submission and Files Biologics License Application for Denosumab
3. ER Doctor Demonstrates Breast Pump on Live TV with Patented New Freemie Hands-Free System
4. NexBio(R) Demonstrates DAS181 (Fludase(R)*), a Broad-Spectrum Drug Candidate, Inhibits Influenza Viral Infection in Human Lung Tissue
5. Data Published in Cell Stem Cell Demonstrates Potent Anti-Cancer Activity for OncoMed Pharmaceuticals Lead Antibody
6. Abbott HIV Test Demonstrates Earlier Disease Detection
7. BioNeutrals Ygiene(TM) Hospital Grade Antimicrobial Demonstrates a 99.9997% Kill Rate Against Clostridium Difficile Spores (C.diff) in Independent Lab Pre-testing Phase
8. New Pre-Clinical Data on OmniGuides BeamPath NEURO(TM) Demonstrates Precise Cutting in Brain Tissue
9. Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late-Stage Leukaemia
10. PROSTVAC(TM) Data Presented at the ASCO Meeting Demonstrates the Potential for Significant Increases in Life Expectancy in Late-Stage Prostate Cancer
11. NIMOTUZUMAB DEMONSTRATES EFFICACY IN RANDOMIZED HEAD & NECK CANCER STUDY WITHOUT THE TOXICITIES ASSOCIATED WITH OTHER EGFR DRUGS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... , Sept. 18, 2014 /PRNewswire-iReach/ -- DeepResearchReports.com adds ... Acetic Acid Industry" and "2014 Deep Research Report ... to its research database. Photo - ... Research Report on Global and China Acetic Acid ... on China and Global ...
(Date:9/18/2014)... 2014 Texas Governor Rick Perry, ... A&M Health Science Center CEO Brett Giroir, M.D., ... and Human Services (HHS), State of Texas and ... influenza vaccine manufacturing facility in Bryan, Texas, which ... the Texas A&M Biocorridor – a rapidly evolving ...
(Date:9/18/2014)... DUBLIN , Sept. 18, 2014 ... the "Global Human Albumin Industry Report 2014" ... Human Albumin Industry Report 2014 is a professional and ... human albumin industry. The report provides a ... and industry chain structure. The human albumin market analysis ...
(Date:9/18/2014)... 2014  MEI Pharma, Inc. (Nasdaq: MEIP ), ... therapies for cancer, announced today that Daniel P. Gold ... BioCentury,s NewsMakers in the Biotech Industry conference on ... the Millennium Broadway Hotel & Conference Center in ... can be accessed at www.meipharma.com . A replay will ...
Breaking Biology Technology:Acetic Acid Market & Sodium Stannate Industry (China, Global) Research Report 2Acetic Acid Market & Sodium Stannate Industry (China, Global) Research Report 3Acetic Acid Market & Sodium Stannate Industry (China, Global) Research Report 4Texas A&M Dedicates National Pandemic Influenza Vaccine Manufacturing Facility, on Track for 2016 Start-Up Phase 2Texas A&M Dedicates National Pandemic Influenza Vaccine Manufacturing Facility, on Track for 2016 Start-Up Phase 3Texas A&M Dedicates National Pandemic Influenza Vaccine Manufacturing Facility, on Track for 2016 Start-Up Phase 4Global Human Albumin Industry Report 2014 2Global Human Albumin Industry Report 2014 3MEI Pharma To Present At BioCentury's NewsMakers Conference 2MEI Pharma To Present At BioCentury's NewsMakers Conference 3
... , , , ... (Nasdaq: GHDX ) today reported financial results and business progress for ... increased to $36.6 million in the second quarter of 2009 compared with $27.8 ... type DX(R) breast cancer test was $35.2 million in the second quarter ...
... 4 Oramed,Pharmaceuticals Inc. (OTCBB: ORMP.OB) ( http://www.oramed.com ... its wholly owned Israeli,subsidiary, Oramed Ltd., was awarded a ... 3.1 million ($828,000), from the Office of the Chief,Scientist ... of Israel. This,grant was awarded as government participation in ...
... , VENLO, The Netherlands, Aug. 4 QIAGEN N.V. (Nasdaq: ... call. The Webcast will take place at 9:30 a.m. EDT on Tuesday, August 11, ... Roland Sackers, Chief Financial Officer. , , ... When: 9:30 a.m. EDT on August 11, ...
Cached Biology Technology:Genomic Health Announces Second Quarter 2009 Financial Results and Business Progress 2Genomic Health Announces Second Quarter 2009 Financial Results and Business Progress 3Genomic Health Announces Second Quarter 2009 Financial Results and Business Progress 4Genomic Health Announces Second Quarter 2009 Financial Results and Business Progress 5Genomic Health Announces Second Quarter 2009 Financial Results and Business Progress 6Genomic Health Announces Second Quarter 2009 Financial Results and Business Progress 7Genomic Health Announces Second Quarter 2009 Financial Results and Business Progress 8Genomic Health Announces Second Quarter 2009 Financial Results and Business Progress 9Oramed Pharmaceuticals was Awarded a NIS 3.1 Million Grant From the Israeli Office of the Chief Scientist 2Webcast of QIAGEN N.V.'s (Nasdaq: QGEN) Second Quarter 2009 Financial Results Call Set for August 11 2
(Date:9/18/2014)... millions of Americans to undertake jaunts into the countryside each ... longer within a century, according to new research. , Climate ... the United States as summer temperatures linger later into the ... Ecology and Biogeography . For instance, the paper birch ... New Hampshire could change color one to three weeks ...
(Date:9/18/2014)... the first smartphone app that automatically reveals students, ... other words, your smartphone knows your state of ... how that affects you. , The StudentLife app, ... to their academic performance, also may be used ... monitor mental health, trigger intervention and improve productivity ...
(Date:9/18/2014)... be cheerful, happy-go-lucky characters, so you might expect that ... , In fact some dogs are distinctly more pessimistic ... , "This research is exciting because it measures ... non-invasively. It offers researchers and dog owners an insight ... said Dr Melissa Starling, from the Faculty of Veterinary ...
Breaking Biology News(10 mins):Fall foliage season may be later, but longer on warmer Earth 2Fall foliage season may be later, but longer on warmer Earth 3Fall foliage season may be later, but longer on warmer Earth 4New Dartmouth smartphone app reveals users' mental health, performance, behavior 2New Dartmouth smartphone app reveals users' mental health, performance, behavior 3New Dartmouth smartphone app reveals users' mental health, performance, behavior 4Dogs can be pessimists too 2Dogs can be pessimists too 3
... understudies. Now, an increasingly popular radioactive isotope has ... at the National Institute of Standards and Technology ... speed up clinical trials of many drugs and ... The number of medical images obtained through ...
... come in boy and girl varieties, but they do have ... Medical Center shows that some of the earliest evolved forms ... higher animals, including that distant cousin of fungus, the human. ... sex-determining genes from one of the oldest known types of ...
... ingestion of soil, or geophagy, has important health ... her colleagues from the Musum National dHistoire Naturelle ... dysfunctional behavior, geophagy has evolved as a practice ... particular study (1), to be published online this ...
Cached Biology News:Radioactive 'understudy' may aid medical imaging, drug development 2Evolution of the sexes: What a fungus can tell us 2Down to earth remedies for chimps 2
... microplate stacker system, offers fast and reliable ... devices:, , Ultra Evolution , SAFIRE monochromator ... SpectraFluor Plus , LS Series of Laser ... a wide range of detection and separation ...
... your life easier. It offers a wide array of ... balance. *Instruments supported: ... XS, XP, PR, SR, PG-S, PG, SG, AT, MT, ... User guidance on the balance ...
... The STag Purification Kits enable rapid ... STag fusion proteins produced from appropriate vectors. ... up to 1 mg target protein under ... incubated with S-protein Agarose, which specifically retains ...
Request Info...
Biology Products: